Tag: Monoclonal Antibodies Cocktail

COVID-19: Zydus Seeks DCGI Approval For Clinical Trial Of Monoclonal Antibodies Cocktail
COVID-19: Zydus Seeks DCGI Approval For Clinical Trial Of Monoclonal Antibodies Cocktail

SARS-CoV-2 spike protein targeted, neutralizing monoclonal antibody based treatments have received emergency use authorization in mild COVID cases in the US, Europe and in India because they significantly reduced viral load in mild patients and their rate of hospitalization.

  • Thursday, 27 May 2021
scrollToTop